SKIP TO CONTENT
30+/SKIN
← BRANDSPRODUCTS 1MEAN SCORE 70TELEHEALTH · UK COMPOUNDED PRESCRIPTION SKINCARE

Skin + Me

The only company in this register that has done anything about the least controlled variable in topical medicine — how much cream a person actually applies. A twist-and-click dispenser meters one evening's dose and will not give you two. It just will not tell you how much a dose is.

MODEL

Online consultation and three photographs, review by dermatologists and pharmacist independent prescribers, dispensing by a partner pharmacy, monthly subscription with a metered daily dispenser.

AGGREGATE
MEAN SCORE70
/ 100
PRODUCTS REVIEWED1
SCORE RANGE70 – 70
PRICE RANGE$29.99 – $29.99 / MO
MEAN DISCLOSURE66 / 100
RECOMMENDED0
CONDITIONAL1
CAUTION0
AVOID0
01

The brand verdict

1 PRODUCTS ASSESSED

One product assessed, and it contains the best single piece of design thinking in this register. Every other topical here — including the FDA-approved ones from Galderma, Bausch Health and Sun Pharmaceutical — asks the patient to judge a pea-sized amount from a squeezable tube. That is a fivefold range of applied dose across a population, and most retinoid irritation is a dose problem before it is a molecule problem. The Daily Doser removes the variable mechanically.

The disclosure of what can be in it is above average for a compounder. The full seven-active pool is published — tretinoin, clindamycin, niacinamide, metronidazole, hydroquinone, hydrocortisone, azelaic acid — with accurate, restrained descriptions of each, including an admission that metronidazole's mechanism is unknown and a correct note that clindamycin should be combined with other agents to limit resistance. Both base creams are published to INCI, with the right antioxidant systems declared: BHT with tretinoin, ascorbic acid and sodium metabisulfite with hydroquinone.

What you cannot know is your own formula. The support centre states that the prescribed treatment cannot be disclosed before a prescriber has reviewed the consultation, so the two decisions a buyer makes — whether to join and what to pay — are both taken without the specification. Published customer plans show tretinoin from 0.006% to 0.05%: the top of that range is well evidenced, and the bottom is roughly a quarter of the lowest concentration any trial has tested.

Two of the seven actives are antibiotics and one is a corticosteroid, all dispensed monthly with no stated review point. The company writes the first half of the antibiotic stewardship argument on its own ingredient page and does not finish it. A monthly dispenser arriving automatically is the format least likely to prompt anyone to ask whether the course should have ended.

WHAT THEY GET RIGHT
  • A metered daily dispenser — the only mechanical dose control in this register.
  • The complete seven-active pool published before purchase.
  • Both base creams published to full INCI, including preservative systems.
  • Declares BHT in tretinoin formulas and ascorbic acid with sodium metabisulfite in hydroquinone formulas.
  • Accurate, unhyped ingredient descriptions, including one admission that a mechanism is unknown.
  • States that clindamycin is best combined with other agents to reduce resistance.
  • Fragrance-free, non-comedogenic, with excluded allergens named.
  • A named menopausal skin route, which is rare in this category and directly relevant to this readership.
  • £29.99 includes ongoing consultations rather than product alone.
  • Ancillary cleanser, moisturiser and sunscreen all sold with volumes and expected duration published.
  • Cancellation available at any time, including during the trial.
02

The range

RANKED BY SCORE
03

What repeats across the range

5 PATTERNS

These are the findings a single review cannot make. Each one appears in more than one product, and each is drawn from the reviews above rather than from an impression of the brand.

04

Disclosure scorecard

WHAT EACH PAGE TELLS YOU

Not what is in the product — what the company publishes about it, and where. “Findable” means the concentration exists somewhere, such as a help-centre article, rather than on the page you buy from.

SCROLL THE TABLE SIDEWAYS

PRODUCTCONC. ON PAGECONC. FINDABLECONTRA-INDICATIONSSIZESIDE EFFECTS
The Daily DoserNOPARTPARTNOPART
05

If you buy one

AND THE ONE TO SKIP
HIGHEST SCORING

The Daily Doser

70CONDITIONAL

Worth buying for a specific person with a specific problem. Read who.

LOWEST SCORING

The Daily Doser

70CONDITIONAL

Worth buying for a specific person with a specific problem. Read who.

BRAND RECORD
TRADING NAMESKIN + ME
FOUNDED2018
MODELTELEHEALTH → PARTNER PHARMACY → MONTHLY DISPENSER
PRESCRIBERSUK CONSULTANT DERMATOLOGISTS AND PHARMACIST INDEPENDENT PRESCRIBERS
RANGE ASSESSED1 PRODUCT
ACTIVE POOL7 — PUBLISHED IN FULL
DOSE CONTROLMETERED DAILY DOSE · VOLUME NOT PUBLISHED
AVAILABILITYUNITED KINGDOM
BRAND PAGES SUMMARISE OUR PUBLISHED REVIEWS. EVERY FACTUAL CLAIM ABOUT A PRODUCT IS SOURCED IN THE REVIEW IT COMES FROM. SCORES ARE FINALISED BEFORE ANY COMMERCIAL LINK IS ATTACHED.
THE DRAW · NO. 01

Win a year of
prescription skincare

One reader gets a 12 months CoreAge Rx derm plan — the compounded, physician-reviewed subscription we take apart in the register. Worth $780. Leave an address and you are entered.

PRIZE
12 MONTHS OF COREAGE RX
VALUE
$780 — $64.99/MO × 12
ENTRY
ONE EMAIL ADDRESS

VALUE IS THE PUBLISHED $64.99/MONTH SUBSCRIPTION PRICE OVER TWELVE MONTHS, AS RECORDED IN R-10. NO PURCHASE NECESSARY. WE REVIEW COREAGE RX — WE DO NOT SELL IT.

DEPTH 000%
THE DRAW · ONE READER

Win a year of
prescription skincare

One reader gets a 12 months CoreAge Rx derm subscription — compounded, physician-reviewed, delivered. The plan we score in the register.

VALUE$780
TERM12 MONTHS$64.99/MO × 12

VALUE IS THE PUBLISHED $64.99/MONTH SUBSCRIPTION PRICE OVER TWELVE MONTHS, AS RECORDED IN R-10. NO PURCHASE NECESSARY. WE REVIEW COREAGE RX — WE DO NOT SELL IT.